1. Smith, A., Roman, E., Howell, D., Jones, R., Patmore, R., Jack, A.: The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research. Br. J. Haematol. 148, 739–753 (2010)
2. Haematological Malignancy Research Network. https://www.hmrn.org/statistics/incidence
3. Devita, V., Canellos, G., Chabner, B., Schein, P., Hubbard, S., Young, R.: Advance diffuse histiocytic lymphoma, a potentially curable disease. Lancet. 305, 248–250 (1975)
4. Yi, P.I., Coleman, M., Saltz, L., Norton, L., Topilow, A.A., Adler, K., Bernhardt, B.: Chemotherapy for large cell lymphoma: a status update. Semin. Oncol. 17, 60–73 (1990)
5. Coltman, C., Dahlberg, S., Jones, S.: CHOP is curative in thirty percent of patients with large cell lymphoma: a twelve-year Southwest Oncology Group follow-up. In: Advances in cancer chemotherapy. pp. 71–78. Park Row, New York (1986)